Microfluidic assembly of monodisperse multistage pH-responsive polymer/porous silicon composites for precisely controlled multi-drug delivery.

We report an advanced drug delivery platform for combination chemotherapy by concurrently incorporating two different drugs into microcompoistes with ratiometric control over the loading degree. Atorvastatin and celecoxib were selected as model drugs due to their different physicochemical properties and synergetic effect on colorectal cancer prevention and inhibition. To be effective in colorectal cancer prevention and inhibition, the produced microcomposite contained hypromellose acetate succinate, which is insoluble in acidic conditions but highly dissolving at neutral or alkaline pH conditions. Taking advantage of the large pore volume of porous silicon (PSi), atorvastatin was firstly loaded into the PSi matrix, and then encapsulated into the pH-responsive polymer microparticles containing celecoxib by microfluidics in order to obtain multi-drug loaded polymer/PSi microcomposites. The prepared microcomposites showed monodisperse size distribution, multistage pH-response, precise ratiometric controlled loading degree towards the simultaneously loaded drug molecules, and tailored release kinetics of the loaded cargos. This attractive microcomposite platform protects the payloads from being released at low pH-values, and enhances their release at higher pH-values, which can be further used for colon cancer prevention and treatment. Overall, the pH-responsive polymer/PSi-based microcomposite can be used as a universal platform for the delivery of different drug molecules for combination therapy.

[1]  Marilena Loizidou,et al.  Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer. , 2009, Trends in pharmacological sciences.

[2]  Robert Langer,et al.  Microfluidic technologies for accelerating the clinical translation of nanoparticles. , 2012, Nature nanotechnology.

[3]  R. Langer,et al.  Drug delivery and targeting. , 1998, Nature.

[4]  W. Freeman,et al.  Porous silicon in drug delivery devices and materials. , 2008, Advanced drug delivery reviews.

[5]  R. K. Shah,et al.  Monodisperse Thermoresponsive Microgels with Tunable Volume‐Phase Transition Kinetics , 2007 .

[6]  Ho Sup Yoon,et al.  Co-delivery of drugs and DNA from cationic core–shell nanoparticles self-assembled from a biodegradable copolymer , 2006, Nature materials.

[7]  E. Teller,et al.  ADSORPTION OF GASES IN MULTIMOLECULAR LAYERS , 1938 .

[8]  P. Cullis,et al.  Drug Delivery Systems: Entering the Mainstream , 2004, Science.

[9]  H. Santos,et al.  Drug permeation across intestinal epithelial cells using porous silicon nanoparticles. , 2011, Biomaterials.

[10]  N. Altorki,et al.  Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer. , 2001, The Lancet. Oncology.

[11]  C. O’Dwyer,et al.  Compositional characterisation of metallurgical grade silicon and porous silicon nanosponge particles , 2013 .

[12]  Anne L. van de Ven,et al.  Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions. , 2013, Nature nanotechnology.

[13]  Sebastian Seiffert,et al.  Microfluidic Synthesis of Advanced Microparticles for Encapsulation and Controlled Release{ a Introduction Lab on a Chip , 2022 .

[14]  Liangfang Zhang,et al.  Polymeric nanoparticles with precise ratiometric control over drug loading for combination therapy. , 2011, Molecular pharmaceutics.

[15]  H. Santos,et al.  Multifunctional porous silicon for therapeutic drug delivery and imaging. , 2011, Current drug discovery technologies.

[16]  Jarno Salonen,et al.  Nanostructured Porous Silicon‐Solid Lipid Nanocomposite: Towards Enhanced Cytocompatibility and Stability, Reduced Cellular Association, and Prolonged Drug Release , 2013 .

[17]  Guojie Wang,et al.  Drug delivery systems for differential release in combination therapy , 2011, Expert opinion on drug delivery.

[18]  J. Salonen,et al.  Stabilization of porous silicon surface by thermal decomposition of acetylene , 2004 .

[19]  Hélder A Santos,et al.  Copper-free azide-alkyne cycloaddition of targeting peptides to porous silicon nanoparticles for intracellular drug uptake. , 2014, Biomaterials.

[20]  Vesa-Pekka Lehto,et al.  Biocompatibility of thermally hydrocarbonized porous silicon nanoparticles and their biodistribution in rats. , 2010, ACS nano.

[21]  Ho Cheung Shum,et al.  Microfluidic generation of multifunctional quantum dot barcode particles. , 2011, Journal of the American Chemical Society.

[22]  E. Kumacheva,et al.  Microfluidic encapsulation of cells in polymer microgels. , 2012, Small.

[23]  Stephen B. Gruber,et al.  Statins and cancer prevention , 2005, Nature Reviews Cancer.

[24]  Sebastian Seiffert,et al.  Controlled synthesis of cell-laden microgels by radical-free gelation in droplet microfluidics. , 2012, Journal of the American Chemical Society.

[25]  J. Baek,et al.  Nanocomposites Derived from Polymers and Inorganic Nanoparticles , 2010, Materials.

[26]  H. Santos,et al.  Functional hydrophobin-coating of thermally hydrocarbonized porous silicon microparticles. , 2011, Biomaterials.

[27]  Michael J Sailor,et al.  Biodegradable luminescent porous silicon nanoparticles for in vivo applications. , 2009, Nature materials.

[28]  F. Kratz,et al.  Finding the optimal balance: challenges of improving conventional cancer chemotherapy using suitable combinations with nano-sized drug delivery systems. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[29]  Kam W Leong,et al.  Microfluidic synthesis of multifunctional Janus particles for biomedical applications. , 2012, Lab on a chip.

[30]  D. Weitz,et al.  Photo- and thermoresponsive polymersomes for triggered release. , 2012, Angewandte Chemie.

[31]  H. Gu,et al.  Delivering hydrophilic and hydrophobic chemotherapeutics simultaneously by magnetic mesoporous silica nanoparticles to inhibit cancer cells , 2012, International journal of nanomedicine.

[32]  Zongxi Li,et al.  Engineered design of mesoporous silica nanoparticles to deliver doxorubicin and P-glycoprotein siRNA to overcome drug resistance in a cancer cell line. , 2010, ACS nano.

[33]  Patrick V. Almeida,et al.  The mechanisms of surface chemistry effects of mesoporous silicon nanoparticles on immunotoxicity and biocompatibility. , 2013, Biomaterials.

[34]  Mauro Ferrari,et al.  Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications. , 2008, Nature nanotechnology.

[35]  H. Santos,et al.  Physicochemical stability of high indomethacin payload ordered mesoporous silica MCM-41 and SBA-15 microparticles. , 2011, International journal of pharmaceutics.

[36]  Chung S Yang,et al.  Combination regimen with statins and NSAIDs: A promising strategy for cancer chemoprevention , 2008, International journal of cancer.

[37]  Mauro Ferrari,et al.  Mesoporous Silicon‐PLGA Composite Microspheres for the Double Controlled Release of Biomolecules for Orthopedic Tissue Engineering , 2012 .

[38]  P. Musto,et al.  Compatibilizing polyimide/silica hybrids by alkoxisilane-terminated oligoimides: Morphology–Properties relationships , 2011 .

[39]  H. Santos,et al.  Nanostructured porous silicon materials: potential candidates for improving drug delivery. , 2012, Nanomedicine.

[40]  Vesa-Pekka Lehto,et al.  Co-delivery of a hydrophobic small molecule and a hydrophilic peptide by porous silicon nanoparticles. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[41]  Hélder A Santos,et al.  Tumour homing peptide-functionalized porous silicon nanovectors for cancer therapy. , 2013, Biomaterials.

[42]  Biana Godin,et al.  Biocompatibility assessment of Si-based nano- and micro-particles. , 2012, Advanced drug delivery reviews.

[43]  Liangfang Zhang,et al.  Nanoparticle-assisted combination therapies for effective cancer treatment. , 2010, Therapeutic delivery.

[44]  J. Salonen,et al.  Humidity behavior of thermally carbonized porous silicon , 2004 .

[45]  H. Santos,et al.  Inhibition of influenza A virus infection in vitro by saliphenylhalamide-loaded porous silicon nanoparticles. , 2013, ACS nano.